Free NAC n = 92 | Malignant NAC invasion n = 33 | Test of significance | |
---|---|---|---|
Age/years Mean ± SD | 43.82 ± 9.61 | 45.12 ± 8.42 | t = 0.691 p = 0.491 |
TS/cm Mean ± SD | 3.55 ± 1.67 | 5.51 ± 2.34 | t = 4.30 p < 0.001* |
n = 72 | n = 21 | ||
≤ 2cm > 2 cm | 13 (18.1) 59 (81.9) | 0 (0.0) 21 (100.0) | χ2 = 4.41 p = 0.036* |
TND/cm Mean±SD | 3.89 ± 2.63 | 2.28 ± 1.94 | t = 4.71 p = 0.032* |
≤ 2cm > 2 cm | 25 (27.2) 67 (72.8) | 21 (63.6) 12 (36.4) | χ2 = 13.88 p < 0.001* |
LP | |||
Mass Non-mass | 72 (78.3) 20 (21.7) | 21 (63.6) 12 (36.4) | χ2 = 2.73 p = 0.09 |
Abnormal nipple enhancement | |||
Present Absent | 2 (2.2) 90 (97.8) | 19 (57.6) 14 (42.4) | χ2 = 53.33 p < 0.001* |
NM (Nipple morphology) | |||
Normal Abnormal (inverted or retracted) | 86 (93.5) 6 (6.5) | 12 (36.4) 21 (63.6) | χ2 = 46.78 p < 0.001* |
Sym NM (symmetry of nipple morphology) | |||
Symmetric Asymmetric | 89 (96.7) 3 (3.3) | 12 (36.4) 21 (63.6) | χ2 = 57.07 p < 0.001* |
TNE (tumor nipple enhancement) | |||
Present Absent | 22 (23.9) 70 (76.1) | 24 (72.7) 9 (27.3) | χ2 = 24.88 p < 0.001* |
PST (peri-areolar skin thickening) | |||
Present Absent | 0 (0.0) 92 (100.0) | 22 (66.7) 11 (33.3) | χ2 = 74.43 p < 0.001* |
TT (tumor type) | |||
DCIS IDC Invasive lobular carcinoma | 3 (3.3) 82 (89.1) 7 (7.6) | 6 (18.2) 27 (81.8) 0 (0.0) | MC p = 0.006* |
TG (tumor grade) | |||
Low or intermediate High | 67 (72.8) 25 (27.2) | 19 (57.6) 14 (42.4) | χ2 = 2.63 p = 0.105 |
LNS (lymph node state) | |||
Positive Negative | 54 (58.7) 38 (41.3) | 17 (51.5) 16 (48.5) | χ2 = 0.510 p = 0.475 |
PR (progesterone receptor) state | |||
Positive Negative | 50 (54.3) 42 (45.7) | 26 (78.8) 7 (21.2) | χ2 = 6.09 p = 0.014* |
HER 2 | |||
positive negative or equivocal | 51 (55.4) 41 (44.6) | 31 (93.9) 2 (6.1) | χ2 = 15.96 p < 0.001* |
KI 67 | |||
High Low | 70 (76.1) 22 (23.9) | 25 (75.8) 8 (24.2) | χ2 = 0.001 p = 0.970 |
ER (estrogen receptor) state | |||
Positive Negative | 63 (68.5) 29 (31.5) | 26 (78.8) 7 (21.2) | χ2 = 1.26 p = 0.262 |